When was bTECH founded?

bTECH was founded in 2016 and raised its 1st funding round 8 years after it was founded.

Where is bTECH located?

bTECH is headquartered in Cleveland, United States.

Who is the current CEO of bTECH?

Wendy Slone of bTECH. They have also founded 1 company.

Is bTECH a funded company?

bTECH is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Mar 11, 2024.

When was the latest funding round of bTECH?

bTECH's latest funding was a $***** Seed round on Mar 11, 2024, with participation from 1 investor.

Where does bTECH rank among its competitors?

bTECH ranks 1875th amongst 1710 active competitors, of which 27 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of bTECH?

bTECH's top competitors include Indegene, IntegriChain and ProPharma Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

bTECH - 2026 Company Profile, Team, Funding & Competitors

Most viewed in 2019

bTECH is a seed company based in Cleveland (United States), founded in 2016 by Wendy Slone. It operates as a Provider of regulatory strategy development services for biopharma sector. bTECH has raised $20K in funding. The company has 1710 active competitors, including 27 funded and 196 that have exited. Its top competitors include companies like Indegene, IntegriChain and ProPharma Group.

Key Metrics

Founded Year

2016

Location

Cleveland, United States

Stage

Seed

Total Funding

$20K in 1 round

Latest Funding Round

Seed, Mar 11, 2024, $*****

Investors

Techstars

Ranked

1875^th among 2045 competitors

Similar Companies

ProPharma Group & 439 more

View bTECH's full profile

bTECH has raised a total funding of $20K over 1 round. Its latest funding round was a Seed round on Mar 11, 2024 for $*****. 1 investor participated in its latest round. bTECH has 1 institutional investor.

Here is the list of recent funding rounds of bTECH:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 11, 2024	6008126	Seed	8585672	8785208	7257199	5015958

Access funding benchmarks and valuations. Sign up today!

View details of bTECH's funding rounds and investors

The founders of bTECH is Wendy Slone. Wendy Slone is the CEO of bTECH.

Here are the details of bTECH's key team members:

Wendy Slone: Founder & CEO of bTECH.
Contact Info: 1 email address

View details of bTECH's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of bTECH include Indegene, IntegriChain and ProPharma Group. Here is the list of Top 10 competitors of bTECH, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Cadawninvestmentcompany, Syneos Health & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	ProPharma Group 2001, Saint Paul (United States), Acquired	Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device	-	Monroe Capital, First Analysis & 4 others	61/100
4th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Capital, Intertrust & 8 others	60/100
5th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Holmes Funding & 3 others	59/100
6th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
7th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
8th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	56/100
9th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Whiterock Finance, Clarendon Fund Managers ... & 4 others	55/100
10th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
1875th	bTECH 2016, Cleveland (United States), Seed	Provider of regulatory strategy development services for biopharma sector	$20K	Techstars	15/100